𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome

✍ Scribed by V. P. Prasher; N. Fung; C. Adams


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
38 KB
Volume
20
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Review of donepezil, rivastigmine, galan
✍ V. P. Prasher πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## Abstract The management of dementia in Alzheimer's disease has dramatically changed since the development of anti‐dementia drugs. However, there is limited information available regarding the bio‐medical aspects of the differing drugs; particularly relating to adults with intellectual disability

End-stae dementia in adults with down sy
✍ Dr. V. Prasher πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 1 views

End-stage dementia in adults with Down syndrome has not been fully investigated. Available information, 6 months prior to death, for 20 adults with Down syndrome who had died with Alzheimer's disease was reviewed. A terminal stage of severe intellectual deterioration, marked personality and mood cha

Plasma Ξ²-amyloid and duration of Alzheim
✍ V. P. Prasher; S. G. Sajith; P. Mehta; W. B. Zigman; N. Schupf πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

## Abstract ## Objectives To investigate the relation of plasma levels of A__Ξ²__ peptides (A__Ξ²__1‐40 and A__Ξ²__1‐42) and apolipoprotein E (APOE) genotype to dementia status, and the duration of Alzheimer's disease (AD) in adults with Down syndrome (DS). ## Methods Adults with DS were recruited